# Evaluation of the Metabolome in Diverticular Disease

> **NCT01831323** · — · UNKNOWN · sponsor: **S.Eugenio Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Simple Diverticular Disease

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3
- **DRUG:** Rifaximin
- **DRUG:** Mesalazine
- **DIETARY_SUPPLEMENT:** Psyllium

## Key facts

- **NCT ID:** NCT01831323
- **Lead sponsor:** S.Eugenio Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831323, "Evaluation of the Metabolome in Diverticular Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01831323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*